Stay updated on Avelumab First-line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.

Latest updates to the Avelumab First-line NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check41 days agoChange DetectedThe website has been updated to version 2.14.2 on January 31, 2025, following the removal of version 2.14.1 on March 20, 2024.SummaryDifference1%
- Check56 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check63 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check92 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.